MedPath

Banner Life Sciences LLC

Banner Life Sciences LLC logo
🇺🇸United States
Ownership
Subsidiary
Employees
11
Market Cap
-
Website
http://www.bannerls.com

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Terminated
Conditions
Relapsing Remitting Multiple Sclerosis
First Posted Date
2023-08-07
Last Posted Date
2025-03-06
Lead Sponsor
Banner Life Sciences LLC
Target Recruit Count
25
Registration Number
NCT05978531
Locations
🇺🇸

Gilbert Neurology, Gilbert, Arizona, United States

🇺🇸

Regina Berkovich MD PhD Inc., West Hollywood, California, United States

🇺🇸

Comprehensive Neurology Clinics of Bethesda Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States

and more 7 locations

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Phase 1
Completed
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: Diroximel Fumarate 462 mg
Drug: Monomethyl Fumarate 190 Mg
First Posted Date
2022-01-06
Last Posted Date
2022-01-06
Lead Sponsor
Banner Life Sciences LLC
Target Recruit Count
46
Registration Number
NCT05181215
Locations
🇺🇸

BioPharma Services, Inc., Saint Louis, Missouri, United States

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate

Withdrawn
Conditions
Relapsing Remitting Multiple Sclerosis
First Posted Date
2021-06-14
Last Posted Date
2021-11-18
Lead Sponsor
Banner Life Sciences LLC
Registration Number
NCT04925778

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Phase 1
Completed
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: monomethyl fumarate 190 mg
Drug: dimethyl fumarate 240 mg
First Posted Date
2020-09-30
Last Posted Date
2022-12-30
Lead Sponsor
Banner Life Sciences LLC
Target Recruit Count
50
Registration Number
NCT04570670

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2019-07-17
Last Posted Date
2020-01-18
Lead Sponsor
Banner Life Sciences LLC
Target Recruit Count
210
Registration Number
NCT04022473
Locations
🇺🇸

BioPharma Services, Inc., Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath